Online News Paper

WASHINGTON: Human trials of a vaccine against the H1N1 (swine flu) virus begin in United States.
Researchers plan to inject roughly 25 volunteers per day over the next five days. They hope to determine not only the vaccine’s safety and effectiveness, but also whether one or two doses are required to produce full immunity to the disease.
Emory is among eight research institutions around the country testing H1N1 vaccines. According to the Word Health Organization, a vaccine could become available to the general public as early as September.